196 related articles for article (PubMed ID: 34946951)
21. A mechanism for the suppression of homologous recombination in G1 cells.
Orthwein A; Noordermeer SM; Wilson MD; Landry S; Enchev RI; Sherker A; Munro M; Pinder J; Salsman J; Dellaire G; Xia B; Peter M; Durocher D
Nature; 2015 Dec; 528(7582):422-6. PubMed ID: 26649820
[TBL] [Abstract][Full Text] [Related]
22. BRCA1-Dependent and Independent Recruitment of PALB2-BRCA2-RAD51 in the DNA Damage Response and Cancer.
Foo TK; Xia B
Cancer Res; 2022 Sep; 82(18):3191-3197. PubMed ID: 35819255
[TBL] [Abstract][Full Text] [Related]
23. PALB2 chromatin recruitment restores homologous recombination in BRCA1-deficient cells depleted of 53BP1.
Belotserkovskaya R; Raga Gil E; Lawrence N; Butler R; Clifford G; Wilson MD; Jackson SP
Nat Commun; 2020 Feb; 11(1):819. PubMed ID: 32041954
[TBL] [Abstract][Full Text] [Related]
24. Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2.
Xia B; Sheng Q; Nakanishi K; Ohashi A; Wu J; Christ N; Liu X; Jasin M; Couch FJ; Livingston DM
Mol Cell; 2006 Jun; 22(6):719-729. PubMed ID: 16793542
[TBL] [Abstract][Full Text] [Related]
25. Palb2 synergizes with Trp53 to suppress mammary tumor formation in a model of inherited breast cancer.
Bowman-Colin C; Xia B; Bunting S; Klijn C; Drost R; Bouwman P; Fineman L; Chen X; Culhane AC; Cai H; Rodig SJ; Bronson RT; Jonkers J; Nussenzweig A; Kanellopoulou C; Livingston DM
Proc Natl Acad Sci U S A; 2013 May; 110(21):8632-7. PubMed ID: 23657012
[TBL] [Abstract][Full Text] [Related]
26. A PALB2-interacting domain in RNF168 couples homologous recombination to DNA break-induced chromatin ubiquitylation.
Luijsterburg MS; Typas D; Caron MC; Wiegant WW; van den Heuvel D; Boonen RA; Couturier AM; Mullenders LH; Masson JY; van Attikum H
Elife; 2017 Feb; 6():. PubMed ID: 28240985
[TBL] [Abstract][Full Text] [Related]
27. Compromised BRCA1-PALB2 interaction is associated with breast cancer risk.
Foo TK; Tischkowitz M; Simhadri S; Boshari T; Zayed N; Burke KA; Berman SH; Blecua P; Riaz N; Huo Y; Ding YC; Neuhausen SL; Weigelt B; Reis-Filho JS; Foulkes WD; Xia B
Oncogene; 2017 Jul; 36(29):4161-4170. PubMed ID: 28319063
[TBL] [Abstract][Full Text] [Related]
28. PALB2 regulates recombinational repair through chromatin association and oligomerization.
Sy SM; Huen MS; Zhu Y; Chen J
J Biol Chem; 2009 Jul; 284(27):18302-10. PubMed ID: 19423707
[TBL] [Abstract][Full Text] [Related]
29. Murine models for familial pancreatic cancer: Histopathology, latency and drug sensitivity among cancers of Palb2, Brca1 and Brca2 mutant mouse strains.
Park D; Shakya R; Koivisto C; Pitarresi JR; Szabolcs M; Kladney R; Hadjis A; Mace TA; Ludwig T
PLoS One; 2019; 14(12):e0226714. PubMed ID: 31877165
[TBL] [Abstract][Full Text] [Related]
30. Heterozygous mutations in PALB2 cause DNA replication and damage response defects.
Nikkilä J; Parplys AC; Pylkäs K; Bose M; Huo Y; Borgmann K; Rapakko K; Nieminen P; Xia B; Pospiech H; Winqvist R
Nat Commun; 2013; 4():2578. PubMed ID: 24153426
[TBL] [Abstract][Full Text] [Related]
31. Male fertility defect associated with disrupted BRCA1-PALB2 interaction in mice.
Simhadri S; Peterson S; Patel DS; Huo Y; Cai H; Bowman-Colin C; Miller S; Ludwig T; Ganesan S; Bhaumik M; Bunting SF; Jasin M; Xia B
J Biol Chem; 2014 Aug; 289(35):24617-29. PubMed ID: 25016020
[TBL] [Abstract][Full Text] [Related]
32. MDC1 and RNF8 function in a pathway that directs BRCA1-dependent localization of PALB2 required for homologous recombination.
Zhang F; Bick G; Park JY; Andreassen PR
J Cell Sci; 2012 Dec; 125(Pt 24):6049-57. PubMed ID: 23038782
[TBL] [Abstract][Full Text] [Related]
33. Assessment of PALB2 as a candidate melanoma susceptibility gene.
Aoude LG; Xu M; Zhao ZZ; Kovacs M; Palmer JM; Johansson P; Symmons J; Trent JM; Martin NG; Montgomery GW; Brown KM; Hayward NK
PLoS One; 2014; 9(6):e100683. PubMed ID: 24949998
[TBL] [Abstract][Full Text] [Related]
34. A systematic review of predicted pathogenic PALB2 variants: an analysis of mutational overlap between epithelial cancers.
Janssen B; Bellis S; Koller T; Tischkowitz M; Liau SS
J Hum Genet; 2020 Jan; 65(2):199-205. PubMed ID: 31619740
[TBL] [Abstract][Full Text] [Related]
35. Non-catalytic Roles for XPG with BRCA1 and BRCA2 in Homologous Recombination and Genome Stability.
Trego KS; Groesser T; Davalos AR; Parplys AC; Zhao W; Nelson MR; Hlaing A; Shih B; Rydberg B; Pluth JM; Tsai MS; Hoeijmakers JHJ; Sung P; Wiese C; Campisi J; Cooper PK
Mol Cell; 2016 Feb; 61(4):535-546. PubMed ID: 26833090
[TBL] [Abstract][Full Text] [Related]
36. Requirement of heterogeneous nuclear ribonucleoprotein C for BRCA gene expression and homologous recombination.
Anantha RW; Alcivar AL; Ma J; Cai H; Simhadri S; Ule J; König J; Xia B
PLoS One; 2013; 8(4):e61368. PubMed ID: 23585894
[TBL] [Abstract][Full Text] [Related]
37. PALB2 (partner and localizer of BRCA2).
Hanenberg H; Andreassen PR
Atlas Genet Cytogenet Oncol Haematol; 2018 Apr; 22(12):484-490. PubMed ID: 31413733
[TBL] [Abstract][Full Text] [Related]
38. MRG Proteins Are Shared by Multiple Protein Complexes With Distinct Functions.
Devoucoux M; Roques C; Lachance C; Lashgari A; Joly-Beauparlant C; Jacquet K; Alerasool N; Prudente A; Taipale M; Droit A; Lambert JP; Hussein SMI; Côté J
Mol Cell Proteomics; 2022 Jul; 21(7):100253. PubMed ID: 35636729
[TBL] [Abstract][Full Text] [Related]
39. Compensatory functions and interdependency of the DNA-binding domain of BRCA2 with the BRCA1-PALB2-BRCA2 complex.
Al Abo M; Dejsuphong D; Hirota K; Yonetani Y; Yamazoe M; Kurumizaka H; Takeda S
Cancer Res; 2014 Feb; 74(3):797-807. PubMed ID: 24285729
[TBL] [Abstract][Full Text] [Related]
40. Structural basis for recruitment of BRCA2 by PALB2.
Oliver AW; Swift S; Lord CJ; Ashworth A; Pearl LH
EMBO Rep; 2009 Sep; 10(9):990-6. PubMed ID: 19609323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
